Jane Street’s Cullinan Therapeutics CGEM Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEM
LCM
KCM
SL
Jane Street's CGEM Position: Q2 2026 in Review
Jane Street sold out of Cullinan Therapeutics (CGEM) in Q2 2026, closing a stake of 22,812 shares — an estimated $339K sold.
Jane Street first reported a position in CGEM in Q1 2023 and held it in 13 quarters. The position peaked at $1.93M in Q4 2025. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.
- Jane Street reported no remaining Cullinan Therapeutics position as of Q2 2026 after selling out during the quarter.
- Jane Street sold 22,812 Cullinan Therapeutics shares in Q2 2026, an estimated $339K.
- Jane Street first reported a position in Cullinan Therapeutics in Q1 2023 and held it in 13 quarters.
- Jane Street's Cullinan Therapeutics position peaked at $1.93M in Q4 2025.
- 183 funds tracked by Wall St. Rank held Cullinan Therapeutics as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.